Low-Dose Eptifibatide for Tandem Occlusion in Stroke: Safety and Carotid Artery Patency.

Alec Jost C Roels M Brown R Janjua Donald V Heck

Published in: AJNR. American journal of neuroradiology (2021)

Low-dose eptifibatide seemed to be safe in tandem occlusions (symptomatic intracranial hemorrhage, 2%), although asymptomatic cervical carotid artery re-occlusions still occurred in 14% of patients.

Keyphrases

low dose
end stage renal disease
high dose
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
optical coherence tomography